PNC-27: Selective Anticancer Peptide Research, HDM2 Targeting & p53 Pathway
What Is PNC-27? PNC-27 is a synthetic peptide designed to selectively induce cell death in cancer cells while leaving normal, non-cancerous cells unaffected.
What Is PNC-27? PNC-27 is a synthetic peptide designed to selectively induce cell death in cancer cells while leaving normal, non-cancerous cells unaffected.
Most research peptides come as salts, not pure free-base forms. The counter-ion matters: acetate, TFA, and HCl salts differ in purity, stability, and research suitability. Here is what every researcher needs to know.
What Is MGF (Mechano Growth Factor)? Mechano Growth Factor (MGF) is a splice variant of insulin-like growth factor 1 (IGF-1) that is produced locally in muscle tissue in response to mechanical loading, stretch, or damage.
AOD-9604 and HGH Fragment 176-191 are both derived from human growth hormone and studied for fat metabolism. Here is what the research actually shows when you compare them head to head.
Complex Regional Pain Syndrome is one of the most difficult-to-treat pain conditions. Research into peptides like BPC-157 and TB-500 explores their potential roles in reducing neuroinflammation and supporting tissue repair.
Post-herpetic neuralgia is one of the most persistent nerve pain conditions after shingles. Research peptides like BPC-157 are being studied for their effects on nerve repair and pain modulation.
What Is Adipotide (FTTP)? Adipotide, also known as FTTP (Fat-Targeted Proapoptotic Peptide) or Prohibitin-TP01, is a synthetic chimeric peptide designed to selectively target and destroy blood vessels supplying white adipose tissue.
Epithalon is studied for telomere lengthening and anti-aging effects. Research participants commonly report improved sleep quality, increased energy, and enhanced well-being. This FAQ explores what the science and participant accounts say about the Epithalon experience.
What Is PE-22-28? PE-22-28 is a synthetic heptapeptide (seven amino acids) derived from spadin, a naturally occurring 17-amino-acid peptide that itself is cleaved from the propeptide of sortilin, also known as the neurotensin receptor 3 (NTSR3) precursor.
Retatrutide (triple GIP/GLP-1/Glucagon agonist) and Mazdutide (dual GLP-1/Glucagon agonist) are the leading next-generation metabolic peptides. Retatrutide produced up to 24.2% weight loss in Phase 2 — the highest ever seen in obesity pharmacology.